Essais liés8clinical trials
VilleEssenlocalisation
PaysGermanylocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07164443

Ouvrir le site du centre

Essais cliniques associés

8
MoléculeIndication / populationPhaseNCTTitreStatut
Nivolumab Cancer Phase 3 NCT06561386 RELATIVITY1093 — A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1% RECRUITING
Pasritamig Cancer Phase 3 NCT07164443 KLK2-comPAS — A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) RECRUITING
Inotuzumab ozogamicin Cancer Phase 2 NCT05748171 A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL RECRUITING
Erenumab Dose 1 Migraine Phase 3 NCT03832998 OASIS(CM) — Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine COMPLETED
CC-97540 Myasthénie Phase 1 NCT06220201 A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2) ACTIVE_NOT_RECRUITING
AOC 1044 Myopathies Phase 3 NCT07587242 SAFARI44 — A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping RECRUITING
Erenumab Dose 1 Migraine Phase 3 NCT03836040 OASIS(EM) — Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine ACTIVE_NOT_RECRUITING
Drisapersen Myopathies À vérifier NCT02636686 Extension Study of Drisapersen in DMD Subjects NO_LONGER_AVAILABLE